A share price of Avanos Medical Inc [AVNS] is currently trading at $14.52, up 1.18%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AVNS shares have gain 2.54% over the last week, with a monthly amount drifted -3.33%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Avanos Medical Inc [NYSE: AVNS] stock has seen the most recent analyst activity on July 25, 2023, when KeyBanc Capital Markets downgraded its rating to a Sector Weight. Previously, CL King started tracking the stock with Buy rating on May 22, 2023, and set its price target to $31. On August 04, 2021, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $45 on the stock. Barclays upgraded its rating to a Equal Weight but stick to its price target of $30 on April 13, 2020. Stifel downgraded its rating to a Hold and reduced its price target to $35 on November 07, 2019. Raymond James downgraded its rating to Mkt Perform for this stock on November 06, 2019. In a note dated October 16, 2018, Barclays initiated an Equal Weight rating and provided a target price of $69 on this stock.
Avanos Medical Inc experienced fluctuations in its stock price throughout the past year between $13.87 and $25.36. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Avanos Medical Inc [NYSE: AVNS] shares were valued at $14.52 at the most recent close of the market. An investor can expect a potential return of 37.74% based on the average AVNS price forecast.
Analyzing the AVNS fundamentals
Trailing Twelve Months sales for Avanos Medical Inc [NYSE:AVNS] were 687.80M which represents 3.64% growth. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -0.56%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.57%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.35 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.28 points at the first support level, and at 14.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.65, and for the 2nd resistance point, it is at 14.77.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Avanos Medical Inc [NYSE:AVNS] is 2.37. As well, the Quick Ratio is 1.53, while the Cash Ratio is 0.65. Considering the valuation of this stock, the price to sales ratio is 0.97, the price to book ratio is 0.81.
Transactions by insiders
Recent insider trading involved Holbrook Kerr, SVP, Chief Commercial Officer, that happened on Mar 06 ’25 when 7000.0 shares were sold. Officer, Holbrook Kerr completed a deal on Mar 06 ’25 to buy 7000.0 shares.
